1 Einträge von mit areas antitrypsin
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:30:40
erkannte Namen Grant Provider | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies more | behring areas | with health | that investigator-initiated | disease including | your research | products quality | investigator diseases | initiated patients | application clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D CSL R&D in Switzerland Investigator Initiated Studies We operate as one integrated global R&D organization Antitrypsin inhibitor to generate data on: Prevalence, epidemiology, natural course of disease and the development of new biomarkers to monitor disease progression Burden of disease Pathophysiology of Alpha-1 Antitrypsin deficienc
Text Inhalt Text aus URL
Log Metriken 86097
erkannte Namen Grant Provider | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies more | behring areas | with health | that investigator-initiated | disease including | your research | products quality | investigator diseases | initiated patients | application clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D CSL R&D in Switzerland Investigator Initiated Studies We operate as one integrated global R&D organization Antitrypsin inhibitor to generate data on: Prevalence, epidemiology, natural course of disease and the development of new biomarkers to monitor disease progression Burden of disease Pathophysiology of Alpha-1 Antitrypsin deficienc
Text Inhalt Text aus URL
Log Metriken 86097